Table 2.
Clinical and microbiological data for the five clinically cured patients positive for DCTB and outcome following 12 months follow up after cure.
PID | Age | Sex | HIV | Hba1c | Smoker | Previous TB | Treatment adherence (%) | BMI Dx | BMI M6 | CXR M6 | CXR M18 | DCTB | Source | Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
253 | 29 | M | NEG | 5.9 | Daily | NO | 100 | 19.2 | 21.3 | Worse | Improved | POS | BLF | Cured |
267 | 57 | M | NEG | 6 | EX | YES | 100 | 18.2 | 21 | No change | No change | POS | BLF/iS | Cured |
338 | 48 | M | NEG | 5.3 | Daily | YES | 99 | 16 | 16.5 | No change | No change | POS | BLF/iS/pbS | Relapse |
370 | 26 | F | NEG | 5.2 | < daily | NO | 100 | 16.5 | 18.6 | Improved | No change | POS | iS | Cured |
404 | 49 | F | NEG | NA | NO | YES | 99 | 16.6 | 15.6 | No change | No change | POS | iS | Relapse |
Source refers to DCTB found in either BALF (BLF), induced sputum (iS) or post-bronch sputum (pbS).